Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic approaches to adoptive cellular immunotherapy

A P Salas1, A E Chang

  • 1Division of Surgical Oncology, University of Michigan, Ann Arbor, Michigan 48109-0932, USA.

Surgical Oncology Clinics of North America
|June 13, 1998
PubMed
Summary

Genetic modification of cells offers new cancer treatment strategies. These advanced techniques create stronger immune cells that can shrink tumors and are now in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The boyfriend catcher. A useful, easy and safe technique to harvest the semitendinous and gracilis autograft for anterior cruciate ligament reconstruction].

Acta ortopedica mexicana·2014
Same author

Use of gene gun for genetic immunotherapy : in vitro and in vivo methods.

Methods in molecular medicine·2012
Same author

Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression.

Cancer gene therapy·2008
Same author

Advanced renal cell carcinoma.

Current treatment options in oncology·2002
Same author

Antitumor reactivity of lymph node cells primed in vivo with dendritic cell-based vaccines.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2002
Same author

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

Cancer research·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Cancer treatment is continuously evolving with novel therapeutic approaches.
  • Genetic engineering offers a promising avenue for enhancing anti-cancer immunity.

Purpose of the Study:

  • To explore the potential of genetically modified cells in cancer therapy.
  • To highlight the development of enhanced immune effector cells for tumor regression.

Main Methods:

  • Cellular engineering to introduce foreign genes.
  • Development of potent immune effector cells.
  • Evaluation of therapeutic efficacy in preclinical models.

Main Results:

  • Genetically modified cells demonstrate enhanced anti-tumor activity.
  • Improved immune cell potency achieved through gene modification.
  • Successful mediation of tumor regression in experimental settings.

Conclusions:

  • Genetic modification of cells represents a significant advancement in cancer treatment.
  • Enhanced immune effector cells hold promise for overcoming established tumors.
  • Clinical trials are underway to assess the safety and efficacy of these novel therapies.

Related Experiment Videos